These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1833116)

  • 41. An evaluation of diabetic retinopathy screening models.
    Okoli U; Mackay K
    J Public Health Med; 2002 Sep; 24(3):190-5. PubMed ID: 12831088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.
    Younis N; Broadbent DM; Vora JP; Harding SP;
    Lancet; 2003 Jan; 361(9353):195-200. PubMed ID: 12547541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of diabetic retinopathy screening using non-mydriatic fundus camera performed by physicians' assistants in the endocrinology service].
    Barcatali MG; Denion E; Miocque S; Reznik Y; Joubert M; Morera J; Rod A; Mouriaux F
    J Fr Ophtalmol; 2015 Apr; 38(4):340-6. PubMed ID: 25892277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London.
    Bryan S; Brown J; Warren R
    J Epidemiol Community Health; 1995 Feb; 49(1):70-8. PubMed ID: 7707010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost--an epidemiologic review.
    Swanson M
    Optometry; 2005 Nov; 76(11):636-46. PubMed ID: 16298316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.
    Kanjee R; Dookeran RI; Mathen MK; Stockl FA; Leicht R
    Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S15-S18. PubMed ID: 29074007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An economic analysis of screening for diabetic retinopathy.
    Bjørvig S; Johansen MA; Fossen K
    J Telemed Telecare; 2002; 8(1):32-5. PubMed ID: 11809082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of sight-threatening diabetic eye disease.
    Leese GP; Broadbent DM; Harding SP; Vora JP
    Diabet Med; 1996 Oct; 13(10):850-3. PubMed ID: 8911777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study.
    Lindenmeyer A; Sturt JA; Hipwell A; Stratton IM; Al-Athamneh N; Gadsby R; O'Hare JP; Scanlon PH
    Br J Gen Pract; 2014 Aug; 64(625):e484-92. PubMed ID: 25071061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening Intervals for Diabetic Retinopathy and Implications for Care.
    Scanlon PH
    Curr Diab Rep; 2017 Sep; 17(10):96. PubMed ID: 28875458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate?
    Baeza M; Orozco-Beltrán D; Gil-Guillen VF; Pedrera V; Ribera MC; Pertusa S; Merino J
    Int J Clin Pract; 2009 Mar; 63(3):433-8. PubMed ID: 19222628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.
    Wonderling D; McDermott C; Buxton M; Kinmonth AL; Pyke S; Thompson S; Wood D
    BMJ; 1996 May; 312(7041):1269-73. PubMed ID: 8634617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sight-threatening diabetic retinopathy at presentation to screening services in Fiji.
    Damato EM; Murray N; Szetu J; Sikivou BT; Emma S; McGhee CN
    Ophthalmic Epidemiol; 2014 Oct; 21(5):318-26. PubMed ID: 25157913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An effective programme to systematic diabetic retinopathy screening in order to reduce diabetic retinopathy blindness.
    Papavasileiou E; Dereklis D; Oikonomidis P; Grixti A; Vineeth Kumar B; Prasad S
    Hell J Nucl Med; 2014; 17 Suppl 1():30-4. PubMed ID: 24392466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of diabetic retinopathy in the community using a non-mydriatic camera.
    Higgs ER; Harney BA; Kelleher A; Reckless JP
    Diabet Med; 1991 Jul; 8(6):551-5. PubMed ID: 1832355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    BMJ; 2002 Jun; 324(7349):1303. PubMed ID: 12039822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides.
    Gibbins RL; Owens DR; Allen JC; Eastman L
    Diabetologia; 1998 Jan; 41(1):59-64. PubMed ID: 9498631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Non mydriatic retinal camera: cost-effectiveness study for early detection of diabetic retinopathy].
    Sender Palacios MJ; Monserrat Bagur S; Badia Llach X; Maseras Bover M; de la Puente Martorell ML; Foz Sala M
    Med Clin (Barc); 2003 Oct; 121(12):446-52. PubMed ID: 14572368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetic retinopathy in a remote Indigenous primary healthcare population: a Central Australian diabetic retinopathy screening study in the Telehealth Eye and Associated Medical Services Network project.
    Brazionis L; Jenkins A; Keech A; Ryan C; Brown A; Boffa J; Bursell S;
    Diabet Med; 2018 May; 35(5):630-639. PubMed ID: 29405370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tele-retina screening of diabetic retinopathy among at-risk populations: an economic analysis.
    Stanimirovic A; Francis T; Shahid N; Sutakovic O; Merritt R; Brent MH; Rac VE
    Can J Ophthalmol; 2020 Feb; 55(1 Suppl 1):8-13. PubMed ID: 31712029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.